Search Results - "PAIMELA, Leena"

Refine Results
  1. 1
  2. 2
  3. 3

    Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica by Karppinen, Jaro, Korhonen, Timo, Malmivaara, Antti, Paimela, Leena, Kyllönen, Eero, Lindgren, Karl-August, Rantanen, Pekka, Tervonen, Osmo, Niinimäki, Jaakko, Seitsalo, Seppo, Hurri, Heikki

    Published in Spine (Philadelphia, Pa. 1976) (15-04-2003)
    “…An open-label study was conducted. To evaluate the efficacy and safety of infliximab, a monoclonal chimeric antibody, against tumor necrosis factor-alpha…”
    Get full text
    Journal Article
  4. 4

    The treatment of disc herniation-induced sciatica with infliximab : Results of a randomized, controlled, 3-month follow-up study by KORHONEN, Timo, KARPPINEN, Jaro, PAIMELA, Leena, MALMIVAARA, Antti, LINDGREN, Karl-August, JÄRVINEN, Simo, NIINIMAKI, Jaakko, VEEGER, Nic, SEITSALO, Seppo, HURRI, Heikki

    Published in Spine (Philadelphia, Pa. 1976) (15-12-2005)
    “…A randomized controlled trial. To evaluate the efficacy of infliximab, a monoclonal antibody against tumor necrosis factor (TNF)-alpha in a randomized…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Efficacy of infliximab for disc herniation-induced Sciatica: One-year follow-up by KORHONEN, Timo, KARPPINEN, Jaro, HURRI, Heikki, MALMIVAARA, Antti, AUTIO, Reijo, NIINIMÄKI, Jaakko, PAIMELA, Leena, KYLLÖNEN, Eero, LINDGREN, Karl-August, TERVONEN, Osmo, SEITSALO, Seppo

    Published in Spine (Philadelphia, Pa. 1976) (01-10-2004)
    “…An open-label trial. To test the long-term efficacy of infliximab, a monoclonal antibody against tumor necrosis factor-alpha (TNF-alpha), in disc…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Effect of treatment on the outcome of very early rheumatoid arthritis by Ritva Peltomaa, Leena Paimela, Tapani Helve, Marjatta Leirisalo-Repo

    “…Objective: To evaluate the effect of treatment on the outcome of very early RA. Methods: In a 3-year prospective study of 27 patients with very early RA (VERA)…”
    Get full text
    Journal Article Conference Proceeding
  9. 9
  10. 10
  11. 11
  12. 12

    Causes of death in patients with rheumatoid arthritis from 1971 to 1991 with special reference to autopsy by Koivuniemi, Riitta, Paimela, Leena, Leirisalo-Repo, Marjatta

    Published in Clinical rheumatology (01-12-2009)
    “…Rheumatoid arthritis (RA) patients have premature mortality, mostly attributed to cardiovascular diseases (CVDs). We studied causes of death (CoDs) and…”
    Get full text
    Journal Article
  13. 13

    Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis by Kuuliala, Antti, Julkunen, Heikki, Paimela, Leena, Peltomaa, Ritva, Kautiainen, Hannu, Repo, Heikki, Leirisalo-Repo, Marjatta

    Published in Rheumatology international (01-11-2013)
    “…In a randomized, double-blind, placebo-controlled trial, 56 patients with recent-onset ReA [enteroarthritis, n  = 47 (84 %); uroarthritis, n  = 9 (16 %)] were…”
    Get full text
    Journal Article
  14. 14

    Work disability in Finnish patients with rheumatoid arthritis: a 15-year follow-up by Tiippana-Kinnunen, Tarja, Paimela, Leena, Peltomaa, Ritva, Kautiainen, Hannu, Laasonen, Leena, Leirisalo-Repo, Marjatta

    Published in Clinical and experimental rheumatology (01-01-2014)
    “…To investigate long-term work disability of patients with early rheumatoid arthritis (RA) and to examine impact of early disease activity and radiological…”
    Get full text
    Journal Article
  15. 15

    High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis by Kuusalo, Laura, Puolakka, Kari, Kautiainen, Hannu, Karjalainen, Anna, Malmi, Timo, Paimela, Leena, Leirisalo-Repo, Marjatta, Rantalaiho, Vappu

    Published in Clinical rheumatology (01-06-2018)
    “…Adverse events (AEs) are common during disease-modifying antirheumatic drug (DMARD) treatment, but their influence on treatment results is unclear. We studied…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Functions of polymorphonuclear leukocytes in early rheumatoid arthritis by LEIRISALO-REPO, M, PAIMELA, L, KOSKIMIES, S, REPO, H

    Published in Inflammation (01-08-1993)
    “…We carried out a prospective study on clinical variables and functions of polymorphonuclear leukocytes (PMNs) of 20 patients with early rheumatoid arthritis…”
    Get full text
    Journal Article
  19. 19

    Amyloidosis is frequently undetected in patients with rheumatoid arthritis by Koivuniemi, Riitta, Paimela, Leena, Suomalainen, Risto, Törnroth, Tom, Leirisalo-Repo, Marjatta

    Published in Amyloid (2008)
    “…Prevalence of AA amyloid in rheumatoid arthritis (RA) is still unclear. The objective of this retrospective study was whether dedicated re-examination of…”
    Get full text
    Journal Article
  20. 20

    Amyloidosis as a cause of death in patients with rheumatoid arthritis by KOIVUNIEMI, R, PAIMELA, L, SUOMALAINEN, R, LEIRISALO-REPO, M

    Published in Clinical and experimental rheumatology (01-05-2008)
    “…To study amyloidosis as a cause of death along with associated factors and frequency of pre-mortem diagnosis in patients with rheumatoid arthritis (RA)…”
    Get full text
    Journal Article